A feasibility analysis from the patient preference randomized phase III clinical trial of second-line chemotherapy (SLC) in advanced gastric cancer (AGC) patients pretreated with both fluoropyrimidines and platinum

被引：0
|
作者：
Park, S.
Lee, S.
Kang, J.
Hwang, I.
Lee, J.
Park, J.
Park, Y.
Lim, H.
Kang, W.
机构：
[1] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea
[2] Dankook Univ Hosp, Cheonan, South Korea
[3] Gyeongsang Natl Univ Hosp, Jinju, South Korea
[4] Chung Ang Univ, Yong San Hosp, Seoul 156756, South Korea
[5] Soon Chun Hyang Univ Hosp, Seoul, South Korea
[6] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea
[7] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.4147
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4147
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A multicenter, randomized phase III trial comparing second-line chemotherapy (SLC) plus best supportive care (BSC) with BSC alone for pretreated advanced gastric cancer (AGC)
    Park, S. H.
    Lim, D. H.
    Park, K.
    Lee, S.
    Oh, S. Y.
    Kwon, H.
    Kang, J. H.
    Hwang, I. G.
    Lee, J.
    Park, J. O.
    Park, Y. S.
    Lim, H. Y.
    Kang, W. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer
    Jin Won Kim
    In Sil Choi
    Yu Jung Kim
    Kyung-Hun Lee
    Keun-Wook Lee
    Tae-Yong Kim
    Sae-Won Han
    Jee Hyun Kim
    Tae-You Kim
    Jong Seok Lee
    Yung-Jue Bang
    Seock-Ah Im
    Do-Youn Oh
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 1175 - 1182
  • [3] A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer
    Kim, Jin Won
    Choi, In Sil
    Kim, Yu Jung
    Lee, Kyung-Hun
    Lee, Keun-Wook
    Kim, Tae-Yong
    Han, Sae-Won
    Kim, Jee Hyun
    Kim, Tae-You
    Lee, Jong Seok
    Bang, Yung-Jue
    Im, Seock-Ah
    Oh, Do-Youn
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (06) : 1175 - 1182
  • [4] A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer
    Ji, Sang Hoon
    Lim, Do Hyoung
    Yi, Seong Yoon
    Kim, Hyo Song
    Jun, Hyun Jung
    Kim, Kyoung Ha
    Chang, Myung Hee
    Park, Min Jae
    Uhm, Ji Eun
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    BMC CANCER, 2009, 9
  • [5] A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer
    Sang Hoon Ji
    Do Hyoung Lim
    Seong Yoon Yi
    Hyo Song Kim
    Hyun Jung Jun
    Kyoung Ha Kim
    Myung Hee Chang
    Min Jae Park
    Ji Eun Uhm
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Won Ki Kang
    BMC Cancer, 9
  • [6] Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial
    Y. Touchefeu
    R. Guimbaud
    C. Louvet
    L. Dahan
    E. Samalin
    E. Barbier
    K. Le Malicot
    R. Cohen
    J. M. Gornet
    T. Aparicio
    S. Nguyen
    A. Azzedine
    P. L. Etienne
    J. M. Phelip
    P. Hammel
    N. Chapelle
    D. Sefrioui
    L. Mineur
    C. Lepage
    O. Bouche
    Gastric Cancer, 2019, 22 : 577 - 586
  • [7] Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial
    Touchefeu, Y.
    Guimbaud, R.
    Louvet, C.
    Dahan, L.
    Samalin, E.
    Barbier, E.
    Le Malicot, K.
    Cohen, R.
    Gornet, J. M.
    Aparicio, T.
    Nguyen, S.
    Azzedine, A.
    Etienne, P. L.
    Phelip, J. M.
    Hammel, P.
    Chapelle, N.
    Sefrioui, D.
    Mineur, L.
    Lepage, C.
    Bouche, O.
    GASTRIC CANCER, 2019, 22 (03) : 577 - 586
  • [8] Randomized phase III trials of second-line chemotherapy in patients with advanced bladder cancer: progress and pitfalls
    Bellmunt, J.
    Choueiri, T. K.
    Schutz, F. A. B.
    Rosenberg, J. E.
    ANNALS OF ONCOLOGY, 2011, 22 (02) : 245 - 247
  • [9] Impact of gastrectomy on efficacy and safety of second-line chemotherapy patients with advanced gastric cancer: Exploratory analysis of two randomized phase III trials
    Nishikawa, Kazuhiro
    Koizumi, Wasaburo
    Tsuburaya, Akira
    Suzuki, Motoko
    Morita, Satoshi
    Fujitani, Kazumasa
    Akamaru, Yusuke
    Shimada, Ken
    Hosaka, Hisashi
    Nishimura, Ken
    Yoshikawa, Takaki
    Tsujinaka, Toshimasa
    Sakamoto, Junichi
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2024,
  • [10] Phase II study of biweekly irinotecan and cisplatin as second-line chemotherapy in pretreated patients with advanced gastric cancer.
    Baek, JH
    Kim, JG
    Sohn, SK
    Song, HS
    Kwon, KY
    Do, YR
    Ryu, HM
    Bae, SH
    Park, GW
    Lee, KH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 325S - 325S
12345